Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
by
Liew, Jean W
, Yazdany, Jinoos
, Kim, Alfred HJ
, Graef, Elizabeth R
, Langguth, Daman
, Konig, Maximilian F
, Simard, Julia
, Gianfrancesco, Milena
, Machado, Pedro M
, Scheetz, Marc H
, Robinson, Philip C
in
Adult
/ Aged
/ Antimalarial agents
/ Antirheumatic Agents - blood
/ Antirheumatic Agents - therapeutic use
/ Betacoronavirus
/ Case-Control Studies
/ Cell culture
/ Chloroquine
/ Clinical trials
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - physiopathology
/ Coronavirus Infections - therapy
/ Coronaviruses
/ COVID-19
/ Disease prevention
/ Disease transmission
/ Dosage
/ Dose-Response Relationship, Drug
/ Drug dosages
/ epidemiology
/ Extracorporeal Membrane Oxygenation - statistics & numerical data
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Hydroxychloroquine
/ Hydroxychloroquine - blood
/ Hydroxychloroquine - therapeutic use
/ Infections
/ Letter
/ Lupus
/ lupus erythematosus, systemic
/ Lupus Erythematosus, Systemic - drug therapy
/ Lupus Erythematosus, Systemic - epidemiology
/ Male
/ Middle Aged
/ Middle East respiratory syndrome
/ Oxygen Inhalation Therapy
/ Oxygenation
/ Pandemics
/ Patients
/ pharmacokinetics
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - physiopathology
/ Pneumonia, Viral - therapy
/ Presidents
/ Respiration, Artificial - statistics & numerical data
/ Rheumatic diseases
/ Rheumatology
/ SARS-CoV-2
/ Severe acute respiratory syndrome coronavirus 2
/ Severity of Illness Index
/ Systemic lupus erythematosus
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
by
Liew, Jean W
, Yazdany, Jinoos
, Kim, Alfred HJ
, Graef, Elizabeth R
, Langguth, Daman
, Konig, Maximilian F
, Simard, Julia
, Gianfrancesco, Milena
, Machado, Pedro M
, Scheetz, Marc H
, Robinson, Philip C
in
Adult
/ Aged
/ Antimalarial agents
/ Antirheumatic Agents - blood
/ Antirheumatic Agents - therapeutic use
/ Betacoronavirus
/ Case-Control Studies
/ Cell culture
/ Chloroquine
/ Clinical trials
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - physiopathology
/ Coronavirus Infections - therapy
/ Coronaviruses
/ COVID-19
/ Disease prevention
/ Disease transmission
/ Dosage
/ Dose-Response Relationship, Drug
/ Drug dosages
/ epidemiology
/ Extracorporeal Membrane Oxygenation - statistics & numerical data
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Hydroxychloroquine
/ Hydroxychloroquine - blood
/ Hydroxychloroquine - therapeutic use
/ Infections
/ Letter
/ Lupus
/ lupus erythematosus, systemic
/ Lupus Erythematosus, Systemic - drug therapy
/ Lupus Erythematosus, Systemic - epidemiology
/ Male
/ Middle Aged
/ Middle East respiratory syndrome
/ Oxygen Inhalation Therapy
/ Oxygenation
/ Pandemics
/ Patients
/ pharmacokinetics
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - physiopathology
/ Pneumonia, Viral - therapy
/ Presidents
/ Respiration, Artificial - statistics & numerical data
/ Rheumatic diseases
/ Rheumatology
/ SARS-CoV-2
/ Severe acute respiratory syndrome coronavirus 2
/ Severity of Illness Index
/ Systemic lupus erythematosus
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
by
Liew, Jean W
, Yazdany, Jinoos
, Kim, Alfred HJ
, Graef, Elizabeth R
, Langguth, Daman
, Konig, Maximilian F
, Simard, Julia
, Gianfrancesco, Milena
, Machado, Pedro M
, Scheetz, Marc H
, Robinson, Philip C
in
Adult
/ Aged
/ Antimalarial agents
/ Antirheumatic Agents - blood
/ Antirheumatic Agents - therapeutic use
/ Betacoronavirus
/ Case-Control Studies
/ Cell culture
/ Chloroquine
/ Clinical trials
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - physiopathology
/ Coronavirus Infections - therapy
/ Coronaviruses
/ COVID-19
/ Disease prevention
/ Disease transmission
/ Dosage
/ Dose-Response Relationship, Drug
/ Drug dosages
/ epidemiology
/ Extracorporeal Membrane Oxygenation - statistics & numerical data
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Hydroxychloroquine
/ Hydroxychloroquine - blood
/ Hydroxychloroquine - therapeutic use
/ Infections
/ Letter
/ Lupus
/ lupus erythematosus, systemic
/ Lupus Erythematosus, Systemic - drug therapy
/ Lupus Erythematosus, Systemic - epidemiology
/ Male
/ Middle Aged
/ Middle East respiratory syndrome
/ Oxygen Inhalation Therapy
/ Oxygenation
/ Pandemics
/ Patients
/ pharmacokinetics
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - physiopathology
/ Pneumonia, Viral - therapy
/ Presidents
/ Respiration, Artificial - statistics & numerical data
/ Rheumatic diseases
/ Rheumatology
/ SARS-CoV-2
/ Severe acute respiratory syndrome coronavirus 2
/ Severity of Illness Index
/ Systemic lupus erythematosus
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Journal Article
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
2020
Request Book From Autostore
and Choose the Collection Method
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism,Elsevier Limited
Subject
/ Aged
/ Antirheumatic Agents - blood
/ Antirheumatic Agents - therapeutic use
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - physiopathology
/ Coronavirus Infections - therapy
/ COVID-19
/ Dosage
/ Dose-Response Relationship, Drug
/ Extracorporeal Membrane Oxygenation - statistics & numerical data
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Hydroxychloroquine - therapeutic use
/ Letter
/ Lupus
/ lupus erythematosus, systemic
/ Lupus Erythematosus, Systemic - drug therapy
/ Lupus Erythematosus, Systemic - epidemiology
/ Male
/ Middle East respiratory syndrome
/ Patients
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - physiopathology
/ Respiration, Artificial - statistics & numerical data
This website uses cookies to ensure you get the best experience on our website.